Q3 2025 Jubilant Ingrevia Ltd Earnings Call Transcript
Key Points
- Jubilant Ingrevia Ltd (BOM:543271) reported significant year-on-year growth in Q3 FY25, driven by enhanced performance in specialty chemicals and nutrition businesses.
- The company announced an interim dividend of 250%, equating to INR2.5 per equity share, resulting in a cash outflow of INR39.8 crores.
- The specialty chemicals segment achieved its highest ever EBITDA of INR121 crores in a quarter, with a 26% EBITDA margin, the highest in the last 14 quarters.
- The company commissioned a new cGMP-compliant vitamin B3 facility in Bharuch, Gujarat, enhancing its presence in the value-added products market.
- Jubilant Ingrevia Ltd received the prestigious Global Lighthouse Network Award from the World Economic Forum for its Bharuch manufacturing facility's integration of Fourth Industrial Revolution technologies.
- The acetyl business faced challenges due to low demand in the paracetamol segment, impacting acetic anhydride volumes and margins.
- Pricing in the chemicals market remains muted, with slow price recovery expected despite volume growth.
- The chemical intermediates business saw a decline in quarterly revenue and EBITDA due to headwinds in the paracetamol market.
- The company faces pricing pressures in the choline segment due to competition from imports.
- The chemical intermediates segment is experiencing low prices, putting pressure on contribution margins.
Ladies and gentlemen, good day, and welcome to Jubilant Ingrevia's Q3 and nine months FY25 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Pavleen Taneja, Head of Investor Relations at Jubilant Ingrevia Limited. Thank you and over to you Mr. Taneja.
Thank you, Nirav. Good evening, everyone. Thank you for joining the quarter three of Financial year 2025 earnings conference call of Jubilant Ingrevia Limited. I would like to remind you that some of the statements made on the call today could be forward-looking in nature. And a detailed disclaimer in this regard has been included in the press release and the results presentation that has been shared on our website.
On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari Bhartia, Co-Chairman; Mr. Deepak Jain, CEO and Managing Director; Mr. Varun Gupta, CFO, Jubilant Ingrevia Limited; and Mr. Arvind Chokhany, Group CFO, Jubilant Bhartia
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
